#1WHERE HOMEBOUND PATIENTS BENEFIT FROM ONSITE TREATMENT, WE GO. WHERE LONG WAITS IN BUSY EMERGENCY ROOMS DO MORE HARM THAN GOOD, WE GO. WHERE UNDERSERVED POPULATIONS NEED BETTER CARE, WE GO. WHERE BASIC TELEHEALTH PROVIDERS STOP, WE GO. AND WHEN ALL REASON SAYS IT CAN'T BE DONE, LEAVE WELL ENOUGH ALONE AND QUIT WHILE YOU'RE AHEAD, WE DO WHAT OUR COMPANY HAS ALWAYS DONE. WE GO. DOCGO © 2022 All Rights Reserved - DocGo DOCGO D 11 BIGNE D Investor Presentation DOC GO DIM -00 beoo D Doc GO →#2DOCGO DISCLAIMER Although the information contained herein is believed to be accurate, DocGo and each of its directors, officers, shareholders, members, partners and representatives, expressly disclaim liability for, and makes no expressed or implied representation or warranty with respect to, any information contained in or omitted from this presentation, or any other information or communication (whether written or oral) transmitted to any prospective investor. Only those representations and warranties made in a definitive agreement with any person shall have any legal effect. This presentation does not constitute (i) a solicitation of a proxy, consent or authorization with respect to any securities or (ii) an offer to sell, a solicitation of an offer to buy, or a recommendation to buy any security of DocGo, any company forming a part of DocGo or any of their respective affiliates. There shall not be any sale of any securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such other jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Investors should make their own independent investigation of DocGo before investing in any securities. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE. Use of Projections and Financial Information This presentation contains financial forecasts relating to the anticipated future financial performance of DocGo and are subject to risks and uncertainties that could cause actual results to differ materially from those statements and should be read with caution. They are subjective in many respects and thus susceptible to interpretations and periodic revisions based on actual experience and recent developments. While presented with numerical specificity, the projections were not prepared in the ordinary course and are based upon a variety of estimates and hypothetical assumptions made by management of DocGo with respect to, among other things, general economic, market, interest rate and financial conditions, the availability and cost of capital for future investment, and competition within DocGo's markets. The projections were not prepared with a view toward compliance with published guidelines of the SEC, the guidelines established by the American Institute of Certified Public Accountants for prospective financial information or generally accepted accounting principles in the United States of America ("GAAP"). None of the assumptions underlying the projections may be realized, and they are inherently subject to significant business, economic and competitive uncertainties and risks, all of which are difficult to predict and many of which are beyond the control of DocGo. Accordingly, there can be no assurance that the assumptions made in preparing the projections will prove accurate, and actual results may materially differ. Furthermore, while all projections are necessarily speculative, DocGo believes that prospective financial information covering periods beyond 12 months from its date of preparation carries increasingly higher levels of uncertainty and should be read in that context. For these reasons, as well as the bases and assumptions on which the projections were compiled, the inclusion of the information set forth below should not be regarded as an indication that the projections will be an accurate prediction of future events, and they should not be relied on as such. Neither DocGo nor any of their respective affiliates, advisors or other representatives has made, or makes, any representation to any stockholder or prospective investor regarding the information contained in the projections and, except as required by applicable securities laws, DocGo does not intend to update or otherwise revise the projections to reflect circumstances existing after the date when made or to reflect the occurrences of future events even in the event that any or all of the assumptions are shown to be in error. Non-GAAP Financial Information This presentation also includes references to financial measures that are calculated and presented on the basis of methodologies other than in accordance with GAAP, such as Earnings Before Interest, Tax, Depreciation and Amortization ("EBITDA") and Adjusted EBITDA. As a result, such information may not conform to SEC Regulation S-X and may be adjusted and presented differently in filings with the SEC. Any non-GAAP financial measures used in this presentation are in addition to, and should not be considered superior to, or a substitute for, financial statements prepared in accordance with GAAP. DocGo has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this presentation that are calculated and presented in accordance with GAAP. Such non-GAAP financial measure should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this presentation. The non-GAAP financial measure in this presentation may differ from similarly titled measures used by other companies. Market and Industry Data Market data and industry data used throughout this presentation is based on information derived from third party sources, the knowledge of the management team of DocGo regarding its industries and businesses and respective management teams' good faith estimates. While management of DocGo believes that the third party sources from which market and industry data has been derived are reputable, DocGo has not independently verified such market and industry data, and you are cautioned not to give undue weight to such market and industry data. © 2023 All Rights Reserved - DocGo DOCGO D GO beoo D 288 2 →#3DOCGO DISCLAIMER (CON'T) Forward Looking Statements This presentation contains forward-looking statements (including within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and Section 27A of the U.S. Securities Act of 1933, as amended) concerning DocGo. These statements include, but are not limited to, statements that address our expected future business and financial performance and statements about (i) our plans, objectives and intentions with respect to future operations, services and products, including our transition to non-COVID related services, geographic expansion, new and existing contracts and our "Zero Emission" initiative, (ii) our competitive position and opportunities,, including our ability to realize the benefits from our operating model, and (iii) other statements identified by words such as "may", "will", "expect", "intend", "plan", "potential", "believe", "seek", "could", "estimate", "judgment", "targeting", "should", "anticipate", "predict" "project", "aim", "goal", "outlook", "guidance", and similar words, phrases or expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as assumptions made by, and information currently available to, management, and current market trends and conditions. Forward-looking statements inherently involve risks and uncertainties, many of which are beyond our control, and which may cause actual results to differ materially from those contained in our forward-looking statements. Accordingly, you should not place undue reliance on such statements. Particular uncertainties that could materially affect current or future results include possible accounting adjustments made in the process of finalizing reported financial results; any risks associated with global economic conditions and concerns; the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, such as the COVID-19 coronavirus pandemic; competitive pressures; pricing declines; rates of growth in our target markets; our ability to improve gross margins; cost-containment measures; legislative and regulatory actions; the impact of legal proceedings and compliance risks; the impact on our business and reputation in the event of information technology system failures, network disruptions, cyber-attacks, or losses or unauthorized access to, or release of, confidential information; and the ability of the company to comply with laws and regulations regarding data privacy and protection. We undertake no intent or obligation to publicly update or revise any of these forward- looking statements, whether as a result of new information, future events or otherwise. This presentation is not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in DocGo and is not intended to form the basis of an investment decision in DocGo. All subsequent written and oral forward-looking statements by DocGo, or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Other Disclaimers No representation or warranty, express or implied, can be made or is made by DocGo as to the accuracy or completeness of any such information. Except where otherwise indicated, this presentation speaks as of the date hereof and is necessarily based upon the information as of the date hereof, all of which are subject to change. DocGo has no obligation to update, bring-down, review or reaffirm this presentation. Under no circumstances should the delivery of this presentation imply that any information or analyses included in this presentation would be the same if made as of any other date. Nothing contained in this presentation is, or shall be relied upon as, a promise or representation as to the past, present or future. This presentation provides summary information only and is being delivered solely for informational purposes. The recipient of this presentation acknowledges that: DocGo does not provide legal, tax or accounting advice of any kind. It is not relying on DocGo for legal, tax or accounting advice, and that the recipient should receive separate and qualified legal, tax and accounting advice in connection with any transaction or course of conduct. Nothing contained herein shall be deemed to be a recommendation from DocGo to any party to enter into any transaction or to take any course of action. This presentation is not intended to provide a basis for evaluating any transaction or other matter. DocGo shall have no liability, whether direct or indirect, in contract or tort or otherwise, to any person in connection with this presentation. INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAS ANY REGULATORY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. THIS PRESENTATION DOES NOT CONSTITUTE AN OFFER OR SOLICITATION OF ANY SECURITIES. © 2023 All Rights Reserved - DocGo DOCGO D 11 DIGI GO DIS beoo D 288 3 →#4DOCGO: LEADING PROVIDER OF LAST MILE MOBILE HEALTHCARE ABOUT DOCGO ➜ DocGo is a mobile health company that has provided service in 29 US states and across the UK The company brings healthcare services to patients where and when they need it in the home, office or via mobile units in the field Delivery of both mobile health and medical transport services are managed logistically by DocGo's proprietary software platform that was developed internally supporting highly efficient and cost-effective delivery of healthcare services Strong revenue growth from inception, 2021 revenues of $318 million with $25 million in Adjusted EBITDA (a) Company revenue guidance is for $430-$440 million in 2022 and $41-$46 million of Adjusted EBITDA (a) © 2023 All Rights Reserved - DocGo DOCGO 11 DGN GO DOCGO BLONDINE Booke Boca D DOCG (H) (a) Adjusted EBITDA is a non-GAAP measure, defined by DocGo as earnings before interest income, interest expense, taxes, depreciation, amortization, stock-based compensation, warrant revaluation and expenses related to DocGo's public listing. D DOCGO GO → 4 →#5CLINICAL DELIVERY OF DOCGO SERVICES DocGo offers a wide variety of services from traditional EMS to mobile urgent care to higher acuity medical services Proven unit economic model utilizes lower-cost health care staff for onsite visits, with higher-cost APPS connected virtually via high resolution video Typical Services Utilized Chronic Care Management ■ Episodic Care Inoculations Patient Transport ■ Prescriptions Remote Patient Monitoring Urgent care ...and more © 2023 All Rights Reserved - DocGo DOCGO D 11 DGN On-Site Clinical Staff Certified Medical Assistant Emergency Medical Technician Licensed Practical Nurse Paramedic dambuinz Remote Clinical Staff Licensed Medical Physician Physician Assistant Nurse Practitioner Registered Nurse ON DEMAND BOC GO DOCGO Flexible, turnkey solution to patient care and recurring management Formulaic usage of Healthcare professionals create efficiency with quality care Common procedures executed at fraction of average industry cost aocod D 8 5 →#6MOBILE HEALTH OFFERINGS Tailored programs create value for key segments ● DOCGO ● ● Government (60% of revenues) Urgent care for low-income communities Drug addiction treatment + Hospitals (30% of revenues) Pre/post-surgical program Emergency department readmission reduction program Remote patient monitoring ● Homeless shelter programs Street medicine programs © 2023 All Rights Reserved - DocGo D 11 DGN 2 BOC GO ● ● ● ● ● ● Payers (<10% of revenues) Annual physical program At-home urgent care Hospital readmission reduction programs Unnecessary ER visit program DOCGO Events (<10% of revenues) Medical services at sports arenas Employee health at convention centers Medical standby at concerts and film shoots beoo D 288 6 →#7FULLY-INTEGRATED FRONT AND BACK-END TECH Multi-modal Software to Better Coordinate Care 2 min 100% 1 Call EASY ORDERING ▪ Digital requesting via Web, Mobile, EMR integrations including Epic, and partner-ready APIs DOCGO TOTAL TRANSPARENCY ▪ Integrated systems providing tracking for hospital staff, receiving facility and family members DEDICATED SUPPORT LINE Prompt, live operator support ■ © 2023 All Rights Reserved - DocGo 11 DIGNE ambuna 70+ 50 Epic S SWATHIR 25 MIN Sve ambuinz 25 W 25, %4, NY 10016 CONTINUE PO GO 「隆隆」 。。 9 MEAT LE 21 Box de laget Aq Lu 13 Our digital platform is fully integrated with industry standard EHR providers and enables a seamless care logistics experience throughout the patient journey TRIP 1675 TERE TO PEOP M Modern Architecture and Design EHR INTEGRATION ● ● MACHINE LEARNING / AI State-of-the-art proprietary system with Al- ● ● Integrated with leading EHRs to enhance functionality & billing/collections DOCGO PATIENT REGISTRATION PORTAL HealthPoint provides an intuitive, user-friendly platform for patient registration, data collection and results reporting SHARELINK™ ● Epic SEACARE powered algorithms Proprietary artificial intelligence-based scheduling (CAD) system with Google traffic data ShareLinkTM technology provides hospitals, patients and their caregivers real-time vehicle location, accurate ETAS and peace of mind HIPAA COMPLIANT &ISO 27001 CERTIFIED Designed for managing sensitive healthcare data, with application infrastructure certification bedoe จ 8 7 →#8SKILLED CLINICIANS Thousands of highly trained clinicians Mobile clinicians consisting of LPNs Paramedics EMTS ■RNS, PAs, NPs, MDs Improved patient care Improved loyalty to company © 2023 All Rights Reserved - DocGo DOCGO D 11 DGN NO *** YER ww Improved employee NPS Improved facility NPS GO GRUBHUB Exceptional employee benefits including Competitive base pay Heavy investment in training Medical insurance Performance bonus DOCGO 401(k) DocGo Employee Equity Incentive Program Improved insurance rates glassdoor Book D 4.4 288 8 D#9A MODEL THAT BENEFITS THE ENTIRE HEALTHCARE ECOSYSTEM Healthcare Professionals ✓ More satisfaction ✓ Better incentives © 2023 All Rights Reserved - DocGo DOCGO D Providers ✓ Superior service ✓ Economic value proposition 11 DGN Patients GO ✓ More convenient Better experience DOCGO Book@ D DOCGO Payers $ ✓ Lower cost ✓ Members access cost-effective care 9 D#10SEGMENT OVERVIEW - MOBILE HEALTH SUMMARY Mobile Health segment represents approximately 75% of revenues DocGo charges a fixed rate per day, per vehicle and per clinician, mitigating volume-based revenue and margin risk Company charges approximately $3,800 per day for a mobile urgent care unit, including vehicle, driver, LPN, RN, APP and social worker, with a target gross margin of approximately 50% at scale (after 3-6 months) Contract terms tend to be one year with auto renew feature for municipal contracts, 2-3 years for state programs and 3+ years for federal contracts Significant new program start up costs for the first 90 days due to use of temporary staffing for rapid expansion Major customers include City of New York, Jefferson Health, Carnival Cruise Lines © 2023 All Rights Reserved - DocGo DOCGO 11 DGN 2 GO DOCE medped TOTAL ADDRESSABLE MARKET $265 BILLION* DOCGO DBOOK@ *US At Home Care. Sources: McKinsey "Telehealth: A quarter trillion-dollar post COVID-19 reality?" (report published 5/29/20), and, McKinsey "From facility to home: How healthcare could shift by 2025" (report published February 2022) D DOCGO GO 10 →#11SEGMENT OVERVIEW-MEDICAL TRANSPORTATION SUMMARY Medical Transportation represents approximately 25% of revenues Providing non-emergency medical transport between clinical settings Leased hour pricing model provides greater financial predictability, approximately $1,500 per day for a dedicated two-person crew and ambulance Combination of cash pay and Insurance/Medicare/Medicaid Existing legacy "fee for service" contracts expected to be transitioned to leased hour contracts by end of 2023 Gross Margin target of 35%+ Major customers include Fresenius, Northwell and HCA © 2023 All Rights Reserved - DocGo DOCGO 11 DGN GO ambuln € *Source: US, Ambulance Only. Management estimates. Deco TOTAL ADDRESSABLE MARKET $7-$13 BILLION* D ambulnz ambuinz 288 by DOCGO 11 →#12ILLUSTRATIVE CUSTOMERS, PARTNERS & PROJECTS Tailored Go-to-Market for each Customer Segment Government CORRECTIONS AND REHABIL STATE OF CALIFORNIA Harris County Public Health Building a Healthy Community M DHHS MIAMI DADE COUNTY NYC OF THE DOCGO UNITED ST Tacoma-Pierce County Health Department Healthy People in Healthy Communities SHL 1859 City of Philadelphia STATE PARTMENT OF STATES VETERANE Department of Homeless Services OF ERICA OF AMERIC HINGTON COLOR 1876 © 2023 All Rights Reserved - DocGo { Florida HEALTH Miami-Dade County MARYLAND Department of Health NJ Health New Jersey Department of Health NEW YORK Department STATE of Health COUNTY OF LOS ANGELES Public Health NYC HEALTH+ HOSPITALS 11 DGN Enterprise / Corporates BARCLAYS CENTER BROOKLYN citi aetna™ FIELD RXR P MIAMI, HEAT CLEAR EQUINOX JAVITS CENTER Royal Caribbean INTERNATIONAL DOLLAR GENERAL PHL PHILADELPHIA INTERNATIONAL AIRPORT GUILD 440[ეკ° BOC GO OF AMERICA L.A. Care HEALTH PLAN® DGA Carnival PACE UNIVERSITY Uber TissorsressERTA Mets Staples beoo FRESENIUS MEDICAL CARE Health Systems Jefferson Martin Luther King, Jr. Community Hospital Northwell HealthSM D DOCGO O Mount Sinai Long Island Select Healthcare, Inc. #UTHealth The University of Texas P88 uchealth 12 →#13CASE STUDY: DEPARTMENT OF HOMELESS SERVICES Growing relationship with city agency, working with licensed practitioners to facilitate vital medical treatment to a traditionally underserved population F M Å Consistent business growth across Mobile Health and Medical Transportation business lines DOCGO Programs promote access to quality care and equitable distribution of medical treatment Relationship has led to additional contracts with city agencies © 2023 All Rights Reserved - DocGo 11 DIGN 0 0 0 12 ~300 homeless shelters Across the city ~19,000 shelter residents Opportunity to provide additional medical services Over 550,000 US homeless Significant opportunity for service expansion to other markets a) According to National Alliance to End Homelessness: State of Homelessness: 2022 Edition BOC GO (a) D Jun 2020 Feb 2021 Apr 2021 Jun 2021 Booke Sep 2021 Jan 2022 Dec 2022 จ DOCGO Launched a vaccine hesitancy education program with six new teams Expanded to 11 medical teams, provided COVID vaccinations Providing medical services at two DHS Isolation Shelters Added six roving street teams, 8 social workers, and additional clinical services Expanded to 16 medical teams servicing shelters, administered HEP-A vaccines Launched three Street Mobile Units, providing expanded medical services to street homeless Signed contract with city for five medical teams to provide COVID testing at homeless shelters GO 13 →#14OUR FOOTPRINT AND REACH DocGo has provided services in 29 US states and the UK Authorized to provide clinical services in 38 states <1% market penetration today © 2023 All Rights Reserved - DocGo DOCGO 11 DGN 2 GO beoo จ DOCGO Mobile Health Only (18) Mobile Health & Medical Transport (12) 288 14 →#15M&A STRATEGY DocGo's forward inorganic strategy is focused on acquiring entities with immediate revenue accretion potential Our three-prong M&A approach is driven by assets that add to core competencies, strategic geographies, and expansionary licensure All acquisitions will look to discontinue lower margin legacy revenue streams of the acquired entity while emphasizing DocGo's superior unit economic model Target businesses with leased-hour, predictable revenue streams or ones that offer the opportunity to move off fee-for-service post acquisition Prevailing thesis of finding businesses where DocGo meets the existing customer base's needs and drive revenue synergies on Day One Disciplined Evaluation Approach Targets Day 1 Synergies Business 'as is' DOCGO Revenue Synergies © 2023 All Rights Reserved - DocGo Cost Financial Synergies Synergies 11 DGN Value to DocGo Value Creation Purchase Price GO Strategy Scope: Three-Prong Approach Core Competencies DOCGO Assets & expert staff that expand DocGo's operational scope into complimentary service areas Mobile Health & Transportation Geography Assets that expand and/or leverage existing occupancies and customer contracts Areas with traditional underserved medical access Licensure Assets that check regulatory requirements and/or expedite organic application processes Provides instant access to new markets and patient populations beoo D P88 15 →#16REQUEST FOR PROPOSAL (RFP) CHANNEL Key Highlights Around Service Distribution Substantially enhanced RFP process and bid volume in Summer 2022 Previously bidding on 2-3 RFPs per month in the $2M - $10M annual revenue range Currently bidding on 2-3 RFPs per week, in the $10 - $200M+ annual revenue range Creation and launch of multiple tools, including 'RFP Finder' and 'RFP Desk Funnel Dashboard' Acquisition of GMS in 2022 opened up access to VA and Indian Health services markets for bid Average RFP process typically lasts 6 months from posting to award, then an additional 30-60 days to start date We expect a material contribution from this channel in 2023 RFP Finder © 2023 All Rights Reserved - DocGo DOCGO Contract Terms RFP Desk Funnel Dashboard GO I Estimated RFP Bidding Process Total RFPs over 6-month period 100 50 0 1H 22 Broader mobile health engagements during post covid ramp up 1H 2022 I I I I I 2H 22 2H 2022 Booke I D +20% Expanded Federal, State, and municipal health bids DOCGO RPM and CCM know-how will expand opportunities to engage upon 1H 23 I 1H 2023 288 I I I 16 →#17PILOT PROGRAMS DocGo is partnering with household brands to provide on-demand care to patients where and when they need it, all done outside the traditional four walls of the medical establishment Looking to leverage our technology & reach, companies all over are looking to initiate innovative partnerships that utilize co-branding techniques for patient care across the map DOLLAR GENERAL Cigna Empire BLUE CROSS aetna™ Dollar General Limited pilot program providing basic primary and urgent care to select Dollar General locations DOCGO Dollar General has 19,000 locations in the US, 70% of which are attractive prospects One unit rotates across three stores Urgent care type reimbursement model Insurance Companies Contracted to provide urgent care and preventative health care services to five major insurance companies, primarily in the Northeast including Aetna, Cigna and Horizon BCBS Covering approximately 10M lives Ability to scale nationally if programs demonstrate success © 2023 All Rights Reserved - DocGo BGK DOC GO DOCGO ON DEMAND Gary and Mary west pace DOCGO DocGo On-Demand Providing primary and urgent care type services at select locations in the Northeast Over 1,000 patient interactions to date - accumulating data to study unit economics Transformative proposition to consumers in need of routine care Remote Patient Monitoring Partnered with West Pace in San Diego to remotely monitor at-risk senior populations When outside parameters, DocGo can provide home visits to remedy and avoid costly ER admissions Collect data to support the unit economic model for both DocGo and payers Booke D 288 17 →#18COMPETITIVE MOAT → T 0 Proprietary Technology & EMR Integrations Rapidly Deployable Staff Laboratory License Clinical Practice Group Medication Dispensory Medicare & Managed Care Credentials DOCGO © 2023 All Rights Reserved - DocGo 8 d! Technology is the nucleus of the value proposition via a proprietary platform that utilizes Al optimization, patient EHR, Hospital integration, and technology-based staffing Winning deals against competitors is attributed to rapidly deployed programs based on 'just-in-time' staffing solutions Licensure enables the company to leverage its personnel for collection, processing, diagnostics and follow up DOCGO Clinical practice group positions our service offering as a nimble alternative to traditional primary and urgent care Ability to act as an Rx eliminates the need for traditional pharmacy streamlining the patient journey Diverse managed care credentials developed competency in the way of health record management and billing for services DocGo has continued to expand its moat, preserving its value proposition by relying on technology to efficiently deploy our resources. The formulaic balance of Al and human specialty has improved DocGo's unit economics, positioning us to disrupt both our competitors and the healthcare market overall. GO beooe D 8 18 →#19Q3 2022 FINANCIAL UPDATE ($ in millions) $13.4 ($4.1) 139% YOY ('22 v. '21) DOCGO $49.7 $0.4 Q1 Q1 117.9 13.6 © 2023 All Rights Reserved - DocGo $22.6 ($0.2) 76% YOY ('22 v. '21) $62.2 Q2 $3.4 Q2 Revenue 109.5 12.3 $26.9 Q3 2020 2021 2022 Adjusted EBITDA 11 OG 22% YoY (22 v. '21) ($0.9) $85.8 $4.0 Q3 2020 2021 2022 $104.3 $8.4 $31.2 288% YoY ('21 v. '20) $121.3 Q4 ($2.9) GO $17.3 Q4 3rd Quarter 2022 Financial Highlights Total revenue increased by 22% YOY to 104.3 million Ex-mass Covid testing, Q3 Mobile Health revenues grew 75% YOY and 18% sequentially Adjusted EBITDA increased by 110% YOY to $8.4 million • Mobile Health revenue increased 12.9% YOY to $76.6 million ● ● ● ● 3rd Quarter 2022 Business Highlights Expanded partnership with Gary and Mary West PACE (West PACE) to launch remote patient monitoring (RPM) to enhance care for PACE participants aged 55 and older within the San Diego market. ● ● DOCGO Transportation Services revenue increased 55% YOY to $27.7 million Announced its mobile health services are now available to Cigna commercial customers in New York and New Jersey, beginning October 1, 2022. Announced that its UK-based subsidiary, Ambulnz Community Partners, has been awarded three new contracts, continuing to drive growth in Greater Manchester while also expanding services in Lancashire and Merseyside. Executed a new contract to provide mobile health services to Horizon Healthcare Services, Inc. (Horizon) members, covering commercial and Medicare members in New Jersey. The agreement allows DocGo to potentially reach an additional 3.8 million people. Booke D GO 19 →#20GROWTH DRIVERS FOR 2023 DocGo's growth strategy will be fueled by the following key components Legacy Customers Mobile Health Pilots Payer Pilot Remote Patient Monitoring RFP Channel M&A Channel ■ DOCGO Continue expansion of existing customers with 3, 4, 5th generation contracts ▪ Build on the success of On-Demand, expand offering and footprint © 2023 All Rights Reserved - DocGo ▪ Mobile Urgent Care service continues to gain network coverage for premier payers ▪ 'Total RPM' being surveyed by large RPM software solutions for patient support DOCGO Large federal opportunities for US Army and VA represent multi-million-dollar deals Disciplined M&A approach will continue to gain access to new services and regions GO accog D 20 →#21EXPERIENCED MANAGEMENT TEAM Presenters Stan Vashovsky Co-Founder, Chairman of the Board Founded DocGo (f/k/a Ambulnz) in 2015 with the vision to revolutionize medical transportation and healthcare delivery DOCGO ▪ Previously executive for services innovations at Philips Healthcare ■ 25+ years of healthcare experience including paramedic work Andre Oberholzer Treasurer and EVP of Capital Markets and Strategy Rosemarie Milano VP, Human Resources © 2023 All Rights Reserved - DocGo Anthony Capone Chief Executive Officer ↑ 11 DIGNE ■ Joined in 2017 as Chief Technology Officer, and built DocGo's Dara Dispatch platform ▪ Previously served as President at Rapid Reliable Testing and Chief Executive Officer of Fundbase ▪ Over 18 years of software engineering experience D Norm Rosenberg Chief Financial Officer BOC GO Ely Tendler General Counsel Dr. James Powell CEO, Clinical Practice Group D Joined DocGo in January 2020 as CFO of Ambulnz Holdings, LLC Promoted to CFO in January 2023 More than 20 years experience as CFO in various companies including telecom and insurance industries BO DBOOK จ DOCGO Lee Bienstock President, COO ■ Joined DocGo in March 2022 as Chief Operating Officer Promoted to President in January 2023 ▪ Spent 10 years at Google, where he most recently served as Global Heat of Enterprise Partnerships for Devices & Services ■ MBA from the Wharton School of Business Stephen Sugrue Chief Compliance Officer Kevin Bland VP, Operations Boc GO 21 D#22KEY TAKEAWAYS Rapid revenue growth, nine quarters of positive adjusted EBITDA, history of beating revenue expectations and raising guidance Significant market and growth opportunity with limited competition DOCGO Early stages of accelerating recurring revenue growth Unique value proposition to healthcare systems and patients Defensible competitive technology advantage Highly attractive customer base Mission-driven company with experienced founder-led management © 2023 All Rights Reserved - DocGo GO aocod D DOCGO P88 22 →